CLINICAL_TRIALS
ClinicalTrials.gov record update
Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer's Disease, and Comparison With CSF Markers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07071649
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:37.535649+00:00
- Published At
- 2026-01-16T00:00:00+00:00
- Record Updated At
- 2026-01-16
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Alzheimer\u0027s Disease", "Biomarkers", "Non-invasive Diagnosis", "Phosphorylated Protein p-tau217"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-16"- protocolSection.identificationModule.nctId
"NCT07071649"- protocolSection.identificationModule.officialTitle
"Evaluation of a Plasma Marker (p-Tau217) for the Biological Diagnosis of Alzheimer\u0027s Disease, and Comparison With CSF Markers"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.